Disc Medicine Files 8-K
Ticker: IRON · Form: 8-K · Filed: Dec 8, 2025 · CIK: 1816736
| Field | Detail |
|---|---|
| Company | Disc Medicine, Inc. (IRON) |
| Form Type | 8-K |
| Filed Date | Dec 8, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, pharmaceutical
TL;DR
Disc Medicine dropped an 8-K on 12/8, check it for deets.
AI Summary
Disc Medicine, Inc. filed an 8-K on December 8, 2025, reporting other events and financial statements/exhibits. The company, formerly known as Gemini Therapeutics, Inc. and FS Development Corp., is based in Watertown, MA, and operates in the pharmaceutical preparations industry. The filing date indicates a report for the period ending December 7, 2025.
Why It Matters
This 8-K filing serves as an official notification of significant events or financial updates for Disc Medicine, Inc., providing transparency to investors and the market.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain any immediately alarming information.
Key Players & Entities
- Disc Medicine, Inc. (company) — Registrant
- Gemini Therapeutics, Inc. (company) — Former Company Name
- FS Development Corp. (company) — Former Company Name
- Watertown, MA (location) — Principal Executive Offices
- December 07, 2025 (date) — Earliest event reported
- December 8, 2025 (date) — Date of Report
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The provided text does not detail the specific 'Other Events' but indicates that this item is being reported.
What is the primary business of Disc Medicine, Inc.?
Disc Medicine, Inc. operates in the 'Pharmaceutical Preparations' industry, SIC code 2834.
When was Disc Medicine, Inc. formerly known as Gemini Therapeutics, Inc.?
The date of name change from Gemini Therapeutics, Inc. was February 9, 2021.
What is the SEC file number for Disc Medicine, Inc.?
The SEC file number for Disc Medicine, Inc. is 001-39438.
Where are Disc Medicine, Inc.'s principal executive offices located?
Disc Medicine, Inc.'s principal executive offices are located at 321 Arsenal Street, Suite 101, Watertown, Massachusetts, 02472.
Filing Stats: 473 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2025-12-08 08:40:17
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share IRON The Nasdaq Global Ma
Filing Documents
- iron-20251207.htm (8-K) — 45KB
- iron-ex99_1.htm (EX-99.1) — 33KB
- iron-ex99_1s1.jpg (GRAPHIC) — 161KB
- iron-ex99_1s2.jpg (GRAPHIC) — 930KB
- iron-ex99_1s3.jpg (GRAPHIC) — 158KB
- iron-ex99_1s4.jpg (GRAPHIC) — 214KB
- iron-ex99_1s5.jpg (GRAPHIC) — 370KB
- iron-ex99_1s6.jpg (GRAPHIC) — 213KB
- iron-ex99_1s7.jpg (GRAPHIC) — 410KB
- iron-ex99_1s8.jpg (GRAPHIC) — 284KB
- iron-ex99_1s9.jpg (GRAPHIC) — 223KB
- iron-ex99_1s10.jpg (GRAPHIC) — 295KB
- iron-ex99_1s11.jpg (GRAPHIC) — 388KB
- iron-ex99_1s12.jpg (GRAPHIC) — 290KB
- iron-ex99_1s13.jpg (GRAPHIC) — 388KB
- iron-ex99_1s14.jpg (GRAPHIC) — 319KB
- iron-ex99_1s15.jpg (GRAPHIC) — 354KB
- iron-ex99_1s16.jpg (GRAPHIC) — 393KB
- iron-ex99_1s17.jpg (GRAPHIC) — 376KB
- iron-ex99_1s18.jpg (GRAPHIC) — 414KB
- iron-ex99_1s19.jpg (GRAPHIC) — 339KB
- iron-ex99_1s20.jpg (GRAPHIC) — 254KB
- iron-ex99_1s21.jpg (GRAPHIC) — 217KB
- iron-ex99_1s22.jpg (GRAPHIC) — 271KB
- iron-ex99_1s23.jpg (GRAPHIC) — 380KB
- iron-ex99_1s24.jpg (GRAPHIC) — 458KB
- iron-ex99_1s25.jpg (GRAPHIC) — 406KB
- iron-ex99_1s26.jpg (GRAPHIC) — 344KB
- iron-ex99_1s27.jpg (GRAPHIC) — 212KB
- iron-ex99_1s28.jpg (GRAPHIC) — 288KB
- iron-ex99_1s29.jpg (GRAPHIC) — 326KB
- iron-ex99_1s30.jpg (GRAPHIC) — 339KB
- iron-ex99_1s31.jpg (GRAPHIC) — 207KB
- 0001193125-25-310664.txt ( ) — 14262KB
- iron-20251207.xsd (EX-101.SCH) — 24KB
- iron-20251207_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On December 7, 2025, Disc Medicine, Inc. (the "Company") held a previously-announced conference call and webcast to review the Company's data presented at the 67th American Society of Hematology ("ASH") Annual Meeting and Exposition and the Company's operational plans. A copy of the slide presentation presented during this conference call and webcast is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Disc Medicine, Inc. presentation, dated December 7, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DISC MEDICINE, INC. Date: December 8, 2025 By: /s/ John Quisel, J.D., Ph.D. Name: John Quisel, J.D., Ph.D. Title: Chief Executive Officer